• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Acute toxicity and depression of phagocytosis in vivo by liposomes: influence of lysophosphatidylcholine.

作者信息

Lutz J, Augustin A J, Jäger L J, Bachmann D, Brandl M

机构信息

Physiologisches Institut, Julius-Maximilians-Universität Würzburg, Germany.

出版信息

Life Sci. 1995;56(2):99-106. doi: 10.1016/0024-3205(94)00419-s.

DOI:10.1016/0024-3205(94)00419-s
PMID:7823764
Abstract

Small unilamellar phospholipid vesicles (liposomes), intended as drug carriers, have recently been demonstrated to reversibly depress phagocytic activity in rats when injected in a single high dose (2g of lipid per kg body weight) as revealed by the carbon clearance test. Depression of the phagocytic function was found to vary widely depending on the lipid used [M. Brandl et al., Pharm. Pharmacol. Lett., 4 (1) 1-4, 1994]. This study has now been extended in two directions: Firstly, liposomes made of the same type of lipid but different batches of raw material were compared in terms of their influence on phagocytosis as well as for their contents of impurities. The test revealed great variability of RES suppression between different batches of hydrogenated soy PC, whereas the reproducibility of the carbon clearance test was satisfactory with liposomes made of a single batch of raw material. Thin layer chromatographic analyses of the used phosphatidylcholines (PCs) and limulus tests on lipopolysaccharides revealed lysophosphatidylcholine (lysoPC) as the only impurity which showed parallels with the observed differences in phagocytosis. Secondly by "spiking" phosphatidylcholine with increasing amounts of lysoPC the latter could be proven to enhance RES depression by liposomes in a dose-dependent manner. At the same time a strong and dose-limiting increase in acute toxicity of PC vesicles was observed with increasing contents of lysoPC. However, in cholesterol-containing vesicles lysoPC-spiking did not significantly alter their behaviour, for lysoPC contents of up to 10%. Only PC/cholesterol-vesicles containing lysoPC contents as high as 15% provoked enhanced RES depression and toxicity compared to lysoPC-free vesicles. LysoPC and cholesterol in liposomes are known to play a destabilizing and stabilizing role respectively within liposomal bilayers which might influence recognition and uptake of vesicles by macrophages and thus modulation of phagocytosis.

摘要

相似文献

1
Acute toxicity and depression of phagocytosis in vivo by liposomes: influence of lysophosphatidylcholine.
Life Sci. 1995;56(2):99-106. doi: 10.1016/0024-3205(94)00419-s.
2
Lysophosphatidylcholine stabilizes small unilamellar phosphatidylcholine vesicles. Phosphorus-31 NMR evidence for the "wedge" effect.溶血磷脂酰胆碱可稳定小单层磷脂酰胆碱囊泡。“楔形”效应的磷-31核磁共振证据。
Biophys J. 1989 Apr;55(4):789-92. doi: 10.1016/S0006-3495(89)82877-2.
3
Lysophosphatidylcholine-cholesterol complex.溶血磷脂酰胆碱-胆固醇复合物
J Biol Chem. 1982 Apr 10;257(7):3570-4.
4
Asymmetry of lysophosphatidylcholine/cholesterol vesicles is sensitive to cholesterol modulation.
Biochemistry. 1988 Jan 12;27(1):393-8. doi: 10.1021/bi00401a059.
5
Formation of vesicles by the action of acyl-CoA:1-acyllsophosphatidylcholine acyltransferase from rat liver microsomes: optimal solubilization conditions and analysis of lipid composition and enzyme activity.大鼠肝脏微粒体中酰基辅酶A:1-酰基溶血磷脂酰胆碱酰基转移酶作用下囊泡的形成:最佳增溶条件及脂质组成与酶活性分析
Biochemistry. 1996 Feb 27;35(8):2644-50. doi: 10.1021/bi952268m.
6
Formation and characterization of phosphatidylethanolamine/lysophosphatidylcholine mixed vesicles.
Biochim Biophys Acta. 2000 Jul 31;1467(1):18-26. doi: 10.1016/s0005-2736(00)00192-9.
7
Modulation of reticuloendothelial activity with liposomes.脂质体对网状内皮系统活性的调节作用
Res Commun Chem Pathol Pharmacol. 1985 Mar;47(3):373-85.
8
Modulation of the biological activity of bacterial endotoxin by incorporation into liposomes.通过包入脂质体对细菌内毒素生物活性进行调节。
J Immunol. 1987 Apr 15;138(8):2663-70.
9
The effect of reticuloendothelial blockade on the blood clearance and tissue distribution of liposomes.网状内皮系统阻断对脂质体血液清除率及组织分布的影响。
Biochim Biophys Acta. 1981 May 18;674(3):354-71. doi: 10.1016/0304-4165(81)90366-4.
10
Liposomes for the sustained drug release in vivo.
Biochim Biophys Acta. 1990 Nov 2;1029(1):91-7. doi: 10.1016/0005-2736(90)90440-y.

引用本文的文献

1
Development of Stable, Maleimide-Functionalized Peptidoliposomes Against SARS-CoV-2.抗SARS-CoV-2的稳定的、马来酰亚胺功能化肽脂质体的研发
Int J Mol Sci. 2025 Feb 14;26(4):1629. doi: 10.3390/ijms26041629.
2
Rediscovery of mononuclear phagocyte system blockade for nanoparticle drug delivery.单核吞噬细胞系统阻断在纳米药物递送中的再发现。
Nat Commun. 2024 May 22;15(1):4366. doi: 10.1038/s41467-024-48838-5.
3
The Chemical Reactivity of Membrane Lipids.膜脂的化学反应性。
Chem Rev. 2024 Mar 27;124(6):3284-3330. doi: 10.1021/acs.chemrev.3c00608. Epub 2024 Mar 18.
4
Entrapment of rosemary extract by liposomes formulated by Mozafari method: physicochemical characterization and optimization.采用莫扎法里法制备的脂质体对迷迭香提取物的包封:理化特性及优化
Heliyon. 2021 Dec 17;7(12):e08632. doi: 10.1016/j.heliyon.2021.e08632. eCollection 2021 Dec.
5
Growth inhibitory effects of PC-NSAIDs on human breast cancer subtypes in cell culture.PC-非甾体抗炎药在细胞培养中对人乳腺癌亚型的生长抑制作用。
Oncol Lett. 2019 Dec;18(6):6243-6248. doi: 10.3892/ol.2019.10951. Epub 2019 Oct 2.
6
Influence on membrane-mediated cell activation by vesicles of silicone oil or perfluorohexyloctane.硅油或全氟己基辛烷囊泡对膜介导的细胞活化的影响。
Graefes Arch Clin Exp Ophthalmol. 2005 Apr;243(4):345-58. doi: 10.1007/s00417-004-1039-z. Epub 2004 Oct 27.
7
Hemoglobin-vesicles as oxygen carriers: influence on phagocytic activity and histopathological changes in reticuloendothelial system.血红蛋白囊泡作为氧载体:对网状内皮系统吞噬活性和组织病理学变化的影响
Am J Pathol. 2001 Sep;159(3):1079-88. doi: 10.1016/S0002-9440(10)61783-X.
8
Adverse drug events related to dosage forms and delivery systems.与剂型和给药系统相关的药物不良事件。
Drug Saf. 1996 Jan;14(1):39-67. doi: 10.2165/00002018-199614010-00005.